Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $931.5M | $997.9M | $1,037.0M | $1,091.1M | $1,237.7M | $1,321.4M | $1,447.0M | $1,678.6M | $1,899.6M | $2,045.5M | $2,322.9M | $2,493.7M | $2,963.7M | $3,435.3M | $3,722.8M | $4,348.0M | $4,386.3M | $5,232.5M | $5,382.4M | $6,004.8M |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Edwards Lifesciences Corporation's last 12-month Revenue is $5,872.6M, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Edwards Lifesciences Corporation's Revenue growth was 0.9%. The average annual Revenue growth rates for Edwards Lifesciences Corporation have been 9.5% over the past three years, 7.2% over the past five years.
Over the last year, Edwards Lifesciences Corporation's Revenue growth was 0.9%, which is higher than industry growth of 0.1%. It indicates that Edwards Lifesciences Corporation's Revenue growth is Good.